
Solos Endoscopy Inc. (PINK:SNDY) aims to reduce some of its debt through consummated agreements that will cut more than $620,000 of its debt for the period ending September 30.
The Boston, Mass.-based company posted a 19 percent decrease in sales for the quarter ended June 30, although it managed to narrow its losses to $186,360, or a loss of 2 cents per share, compared to $229,973 lost, or 82 cents lost per diluted share in Q2 of 2010.
The details of the agreements were not released, but Solos expects to save about $60,000 per quarter in ongoing expenses, according to a press release.
Solos recently broke into the pet care market with the announcement that it launched its revamped veterinary product line of endoscopic equipment, scopes and instruments.